Characteristics of control subjects and case subjects with t(14;18)-positive and t(14;18)-negative non-Hodgkin lymphoma (NHL)
. | . | Case subjects . | . | |
---|---|---|---|---|
Characteristic . | Control subjects, no. (%) . | t(14;18)-positive, no. (%) . | t(14;18)-negative, no. (%) . | |
Sex | ||||
Male | 725 (50.6) | 33 (50.8) | 43 (40.2) | |
Female | 707 (49.4) | 32 (49.2) | 64 (59.8) | |
Respondent status | ||||
Self | 808 (56.4) | 40 (61.5) | 60 (56.1) | |
Proxy | 624 (43.6) | 25 (38.5) | 47 (43.9) | |
Used tobacco products | ||||
Never | 677 (47.3) | 38 (58.5) | 51 (47.7) | |
Ever | 749 (52.3) | 27 (41.5) | 56 (52.3) | |
Used hair dye | ||||
Never | 976 (71.1) | 48 (73.9) | 70 (65.4) | |
Ever | 386 (28.1) | 17 (26.2) | 37 (34.6) | |
Family history of cancer | ||||
No | 908 (64.6) | 32 (50.8) | 62 (59.6) | |
Nonhematopoietic cancer | 419 (29.8) | 25 (39.7) | 31 (29.8) | |
Hematopoietic cancer | 78 (5.6) | 6 (9.5) | 11 (10.6) | |
WHO-defined histologic types | ||||
Follicular lymphoma | NA | 42 | 21 | |
Diffuse large B-cell lymphoma | NA | 21 | 44 | |
Small lymphocytic lymphoma | NA | 1 | 17 | |
Other* | NA | 1 | 25 |
. | . | Case subjects . | . | |
---|---|---|---|---|
Characteristic . | Control subjects, no. (%) . | t(14;18)-positive, no. (%) . | t(14;18)-negative, no. (%) . | |
Sex | ||||
Male | 725 (50.6) | 33 (50.8) | 43 (40.2) | |
Female | 707 (49.4) | 32 (49.2) | 64 (59.8) | |
Respondent status | ||||
Self | 808 (56.4) | 40 (61.5) | 60 (56.1) | |
Proxy | 624 (43.6) | 25 (38.5) | 47 (43.9) | |
Used tobacco products | ||||
Never | 677 (47.3) | 38 (58.5) | 51 (47.7) | |
Ever | 749 (52.3) | 27 (41.5) | 56 (52.3) | |
Used hair dye | ||||
Never | 976 (71.1) | 48 (73.9) | 70 (65.4) | |
Ever | 386 (28.1) | 17 (26.2) | 37 (34.6) | |
Family history of cancer | ||||
No | 908 (64.6) | 32 (50.8) | 62 (59.6) | |
Nonhematopoietic cancer | 419 (29.8) | 25 (39.7) | 31 (29.8) | |
Hematopoietic cancer | 78 (5.6) | 6 (9.5) | 11 (10.6) | |
WHO-defined histologic types | ||||
Follicular lymphoma | NA | 42 | 21 | |
Diffuse large B-cell lymphoma | NA | 21 | 44 | |
Small lymphocytic lymphoma | NA | 1 | 17 | |
Other* | NA | 1 | 25 |
For control subjects, n = 1432; for t(14;18)-positive case subjects, n = 65; for t(14;18)-negative case subjects, n = 107 (numbers in table may not sum to overall totals because of missing data).
NA indicates not applicable.
Other includes Burkitt-like NHL (n = 1), lymphoplasmacytic NHL (n = 2), mantle cell NHL (n = 4), marginal zone NHL (n = 4), plasmacytoma (n = 2), unclassifiable B-cell NHL (n = 1), and T-cell NHL (n = 12).